Dow Down 1.29% Nasdaq Down 3.25%

CytRx Corporation (CYTR)

-NasdaqCM
1.77 Down 0.12(6.35%) Feb 5, 4:00PM EST
|After Hours : 1.77 0.00 (0.00%) Feb 5, 4:49PM EST
Prev Close:1.89
Open:1.87
Bid:1.77 x 1700
Ask:1.98 x 1200
1y Target Est:7.40
Beta:2.94996
Earnings Date:Mar 8 - Mar 14 (Est.)
Day's Range:1.77 - 1.89
52wk Range:1.55 - 5.42
Volume:385,994
Avg Vol (3m):469,052
Market Cap:117.67M
P/E (ttm):N/A
EPS (ttm):-0.86
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
CYTRDown 6.35%117.67M
LLYUp 0.05%78.70B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):1,256.47
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-15) :-0.81
Quarterly EPS Est (Dec-15) :-0.20
Mean Recommendation*:1.8
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

CytRx Corporation operates as a biopharmaceutical research and development company specializing in oncology. The company’s product candidate is aldoxorubicin, which is in Phase III clinical trial as a therapy for patients with soft tissue sar... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback